Effects of Transportation Choices on Commuter Health
ETCH
2 other identifiers
observational
65
1 country
1
Brief Summary
The primary project objective is to investigate how an individual's choices influence personal exposures to traffic-related air pollutants (TRAPs) and the corresponding acute health effects. TRAPs are a complex mixture of particulate and gaseous pollutants that vary considerably spatially and temporally. There is increasing evidence that TRAPs inflict a broad range of deleterious health effects in both health-compromised and healthy individuals, and it has been reported that traffic pollutants may cause up to half of all air pollution-related mortalities. Despite the burden from such widespread, involuntary exposures, few studies have examined the magnitude of personal exposures due to commuting exposures. Most commuters travel to and from work during two peak travel periods, which occur during weekday mornings and evenings. Public transportation, bicycling, and walking have been promoted as ways to reduce air pollution by reducing the vehicle fleet, yet few studies have examined how exposures are modified due to an intentional change in the time of commute or the subsequent health effects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 6, 2023
CompletedFirst Submitted
Initial submission to the registry
February 15, 2023
CompletedFirst Posted
Study publicly available on registry
March 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 24, 2025
CompletedJune 11, 2025
June 1, 2025
2.2 years
February 15, 2023
June 10, 2025
Conditions
Outcome Measures
Primary Outcomes (5)
Blood Pressure measurements before and after the sampling period
Systolic and Diastolic measured on the non-dominant arm
Collected pre and post each 48-hour sampling period of each participant (4 measurements per participant). Participants will complete all measurements within one season.
Changes in FEV1 (Spirometry)
FEV is short for forced expiratory volume. FEV1 is the amount of air you can force from your lungs in one second. It's measured during a spirometry test, also known as a pulmonary function test, which involves forcefully breathing out into a mouthpiece connected to a spirometer machine.
Collected pre and post each 48-hour sampling period; also collected after each commute (8 measurements per participant). Participants will complete all measurements within one season.
Changes in FVC (Spirometry)
Forced vital capacity (FVC) is the total amount of air exhaled during the FEV test. Forced expiratory volume and forced vital capacity are lung function tests that are measured during spirometry.
Collected pre and post each 48-hour sampling period; also collected after each commute (8 measurements per participant). Participants will complete all measurements within one season.
Exhaled Nitric Oxide before and after sampling period
Identifies airway inflammation
Collected pre and post each 48-hour sampling period (4 measurements per participant). Participants will complete all measurements within one season.
Presence of urinary biomarkers of exposures to polycyclic aromatic hydrocarbons (PAHs) and nitro-PAHs (nPAHs) in urine
Urinary biomarkers of PAHs and nPAHs exposures can be utilized to evaluate systemic inflammation.
Collected after each 48-hour sampling period (2 measurements per participant). Participants will complete all measurements within one season.
Study Arms (1)
Hartford Commuters
Eligibility Criteria
This study will include 65 working adults (age 18 years and over) who live in Hartford County, CT. Both males and females will be recruited into the study. The study will include all racial/ethnic groups for this study in an attempt to be representative of the Hartford population.
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
Study Sites (1)
UConn Health
Farmington, Connecticut, 06030, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Misti L Zamora, PhD
UConn Health
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
February 15, 2023
First Posted
March 7, 2023
Study Start
February 6, 2023
Primary Completion
April 14, 2025
Study Completion
April 24, 2025
Last Updated
June 11, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share